超极化13C MRI可评估前列腺癌小鼠放疗早期剂量依赖性反应
该研究在前列腺癌转基因小鼠模型(n=18)中,采用单次大剂量放疗(肿瘤跨度4–14 Gy)并结合超极化13C MRI同时评估代谢与灌注,发现响应肿瘤的丙酮酸-乳酸转化显著下降且呈剂量依赖性,提示该技术可早期监测放疗生理变化。
要点
- 超极化13C MRI可同时评估肿瘤代谢与灌注,监测放疗后早期生理变化。
- 响应肿瘤的丙酮酸-乳酸转化显著下降,且高剂量区(10–14 Gy)比低剂量区(4–7 Gy)下降更明显。
- 表观扩散系数在放疗后7天内无统计学显著变化。
核心结论
- 超极化13C MRI能够以及时、剂量依赖的方式监测放疗诱导的生理变化,为进一步临床研究和转化提供基础科学前提。
研究设计与样本
- 研究纳入转基因小鼠前列腺腺癌(TRAMP)小鼠18只,接受单次分次放疗(肿瘤跨度4–14 Gy陡峭剂量),在放疗前基线及放疗后第1、4、7天连续行超极化13C MRI(联合[1-13C]丙酮酸和[13C]尿素)及常规多参数1H MRI。
- 放疗后第4天和第7天收集肿瘤组织进行生物学相关性研究。
主要发现
- 响应放疗的肿瘤中超极化丙酮酸-乳酸转化显著下降,同时超极化丙酮酸-丙氨酸转化和超极化尿素信号显著增加;放疗抵抗肿瘤则呈现相反变化。
- 超极化乳酸变化呈剂量依赖性,高剂量区(10–14 Gy)在放疗后第1天即比低剂量区(4–7 Gy)表现出更大幅度的超极化乳酸信号下降,与乳酸脱氢酶活性和表达数据一致。
- 超极化[13C]尿素MRI提供的肿瘤灌注评估与1H动态对比增强MRI相似。
- 表观扩散系数这一常规1H MRI功能生物标志物在放疗后7天内未显示统计学显著变化。
临床怎么用
- 超极化13C MRI可作为放疗早期疗效评估的潜在影像生物标志物,通过代谢与灌注同步成像识别剂量依赖性反应。
- 该技术为后续临床研究和转化提供了基础科学依据,但尚需临床验证。
局限性
- 研究仅在前列腺癌小鼠模型中进行,样本量有限(n=18),结论向临床转化需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate use of a novel imaging approach, hyperpolarized (HP) 13C magnetic resonance imaging (MRI) for simultaneous metabolism and perfusion assessment, to evaluate early and dose-dependent response to radiation therapy (RT) in a prostate cancer mouse model. METHODS AND MATERIALS: Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice (n = 18) underwent single-fraction RT (4-14 Gy steep dose across the tumor) and were imaged serially at pre-RT baseline and 1, 4, and 7 days after RT using HP 13C MRI with combined [1-13C]pyruvate (metabolic active agent) and [13C]urea (perfusion agent), coupled with conventional multiparametric 1H MRI including T2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging. Tumor tissues were collected 4 and 7 days after RT for biological correlative studies. RESULTS: We found a significant decrease in HP pyruvate-to-lactate conversion in tumors responding to RT, with concomitant significant increases in HP pyruvate-to-alanine conversion and HP urea signal; the opposite changes were observed in tumors resistant to RT. Moreover, HP lactate change was dependent on radiation dose; tumor regions treated with higher radiation doses (10-14 Gy) exhibited a greater decrease in HP lactate signal than low-dose regions (4-7 Gy) as early as 1 day post-RT, consistent with lactate dehydrogenase enzyme activity and expression data. We also found that HP [13C]urea MRI provided assessments of tumor perfusion similar to those provided by 1H dynamic contrast-enhanced MRI in this animal model. However, apparent diffusion coefficien , a conventional 1H MRI functional biomarker, did not exhibit statistically significant changes within 7 days after RT. CONCLUSION: These results demonstrate the ability of HP 13C MRI to monitor radiation-induced physiologic changes in a timely and dose-dependent manner, providing the basic science premise for further clinical investigation and translation.
引用
- Qin H, Zhang V, Bok RA, et al. Simultaneous Metabolic and Perfusion Imaging Using Hyperpolarized 13C MRI Can Evaluate Early and Dose-Dependent Response to Radiation Therapy in a Prostate Cancer Mouse Model. Int J Radiat Oncol Biol Phys. 2020. PMID: 32339646. doi:10.1016/j.ijrobp.2020.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。